Skip to content

Author

E. Vrdoljak

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Time-varying association of first-line bevacizumab with progression-free survival in advanced ovarian cancer: A multicenter matched cohort study.

Randomized trials have demonstrated that first-line bevacizumab extends progression-free survival (PFS) in advanced ovarian cancer. However, its long-term effectiveness in routine clinical practice remains unclear. This study investigated the time-varying association between first-line bevacizumab and PFS in patients n...

K. Katić, Dora Čerina Pavlinović, I. Canjko et al. · 0 citations
Open access Sep 2026

Hereditary Cancer Gene Panel Testing in a Croatian Cohort: The First Results from the University Hospital of Split

Background and Objectives: Hereditary cancer predisposition is associated with pathogenic germline variants in numerous genes. Identification of inherited cancer susceptibility enables personalized screening, preventive interventions, and targeted therapies. It also facilitates cascade testing of relatives who may be a...

Tomislav Smoljo, Marin Ogorevc, Toni Čeprnja et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.